Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 34 Lung Neoplasms 23 Carcinoma, Non-Small-Cell Lung 18 Neoplasms 15 Uterine Cervical Neoplasms 9 Esophageal Neoplasms 9 Brain Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Solid Tumor 7 Rectal Neoplasms 7 Lymphoma 7 Glioblastoma 7 Carcinoma, Hepatocellular 7 Prostatic Neoplasms 6 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Melanoma 6 Hodgkin Disease 6 Colorectal Neoplasms 6 Colonic Neoplasms 6 Carcinoma, Renal Cell 6 Breast Neoplasms, Male 6 Stomach Neoplasms 5 Sarcoma 5 Neuroendocrine Tumors 5 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Transitional Cell 5 Thyroid Neoplasms 4 Ovarian Neoplasms 4

Interventions

Fluorodeoxyglucose F18 1 Cytoreduction Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cytoreductive Surgery × Fluorodeoxyglucose F18 × Clear all

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡